Bayer today announced the appointment of Dr Carsten Brunn as president of its pharmaceuticals business in the Americas, comprising the USA, Canada, Central and Latin America. 17 January 2017
Friday saw the launch of a new US biotech company, Vir Biotechnology, which is focussed developing cures, treatments and preventions for challenging infectious diseases, with former Biogen chief executive George Scangos heading a team of scientific and industry leaders. 9 January 2017
3SBio announced today that Zhenping Zhu will join the Chinese biotech firm as president of research & development and chief scientific officer. 9 January 2017
The new man at the helm of Eli Lilly has started off his time as the US pharma major’s chief executive by announcing a series of organizational and leadership structure changes. 6 January 2017
David-Alexandre “DA” Gros has joined Neurocrine Biosciences as president and chief operating officer, the American biotech group announced today. 6 January 2017
Biotech firm Sobi have announced the recruitment of Armin Reininger as senior vice president and head of global medical and scientific affairs. 5 January 2017
US-based biotech firm Gilead has recruited Alessandro Riva as senior vice president of hematology and oncology. Dr Riva helped develop more than 20 cancer compounds as head of oncology at Swiss giant Novartis, including both targeted and immune-oncology treatments. 4 January 2017
Ireland-headquartered Shire has announced the appointment of Ian Clark as a non-executive director of the company with effect from today (January 3). 3 January 2017
Provectus Biopharmaceuticals has said that, on December 27, 2016, its board of directors unanimously voted to terminate Peter Culpepper, effective immediately, from all positions held with the company, including chief executive and chief operating officer. 30 December 2016
US fertility treatment specialist OvaScience lost nearly a third of its value after it announced major workforce cuts and the departure of two top executives. 22 December 2016
News that AstraZeneca was losing the experienced head of one its focus areas caused a slight share price wobble on Monday – but the company is confident that his shoes will be ably filled. 21 December 2016
US biotech major Biogen has now selected a new chief executive to replace outgoing incumbent George Scangos, who has led the company since 2010 but announced his intention to leave last year, from its own ranks. 20 December 2016
Genentech, the US-based biotech unit of Swiss pharma giant Roche, has announced its new chief executive after the retirement of Ian Clark. 16 December 2016
Troubled Valeant Pharmaceuticals has announced the departure of three executives, as the business continues to restructure at the close of a punishing 2016. 14 December 2016
Shares of US biotech firm Alexion Pharmaceuticals plunged as much as 15.6% to $111.44 on Monday, after it was revealed that its chief executive David Hallal had resigned for personal reasons, and chief financial officer Vikas Sinha was leaving to pursue other opportunities. 13 December 2016
Effective February 1, 2017, Robert LaCaze will become executive vice president of the new Oncology Strategic Business unit at the Pharmaceuticals Division of German pharma major Bayer. 13 December 2016
A new man is at the helm of the European Federation of Pharmaceutical Industries and Association (EFPIA) after the departure of Richard Bergström. 12 December 2016
Privately-held UK biotech Curve Therapeutics today announced the further strengthening of its leadership team with the appointments of Andre Hoekema as chairman of the board and Cora Griffin as head of business development. 2 October 2024
NK:IO, a London startup developing a cell therapy for treating solid tumors, has announced the appointment of a permant chief executive and the finalization of a seed funding round. 2 October 2024
Halda Therapeutics, a US biotech company advancing cancer treatments, announced the appointment of Christian Schade as president and chief executive. 1 October 2024
Nxera Pharma has entered a new commercial partnership agreement with fellow Japanese drugmaker Shionogi regarding the distribution and sales for Quviviq (daridorexant 25 and 50mg) in Japan. 1 October 2024
AstronauTx, a biotech developing novel treatments for Alzheimer's disease and other neurodegenerative disorders, has announced the appointment of Jane Rhodes as chief executive officer. 1 October 2024
Privately-held German pain specialist Grünenthal has appointed Jan Adams its new chief commercial officer (CCO) and a member of the corporate executive board. 30 September 2024
USA-based engineered regulatory T cells (Tregs) company GentiBio today announced the appointment of Dr Mark Bach as chief medical officer. 30 September 2024
Acadia Pharmaceuticals has appointed Catherine Owen Adams to succeed Steve Davis as chief executive (CEO) and a member of its board of directors. 28 September 2024
Recently-created by US biotech incubator Flagship Pioneering, Abiologics has announced the appointment of Maria-Chiara Magnone as its chief scientific officer. 26 September 2024
German privately-held biotech ARTCLINE Bio-Therapies today announced the appointment of Dirk Hessel as additional managing director of the company. 23 September 2024
Stalicla, a privately-held Swiss biotech, today announced that Dr Paulo Fontoura will be joining its drug development team as chief scientific and clinical development advisor. 19 September 2024
US contract development and manufacturing organization (CDMO) BioCentriq has appointed Syed Husain as its new chief executive (CEO), and as a member of the board of directors. 19 September 2024
Structure Therapeutics, a specialist in small molecule treatments for metabolic and pulmonary diseases, has announced key leadership appointments. 18 September 2024
Californian biopharma 89bio, a company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, has announced an important appointment. 17 September 2024
British biotech IMU Biosciences has announced key changes to its leadership team as it looks to grow in the field of precision medicine. 17 September 2024
Ohio, USA-based Trailhead Biosystems has appointed Josh Snow as its new chief commercial officer, as the company moves to expand its presence in the commercial market with its iPSC-derived human cell products. 16 September 2024
Under pressure from certain shareholders, autoimmune diseases specialist Aurinia Pharmaceuticals on Friday said it has restructured its board of directors. 14 September 2024
US neurological diseases specialist Ovid Therapeutics has announced the promotion of Meg Alexander to president and chief operating officer (COO). 12 September 2024